References
- 1. Proudfoot AT. Aluminium and zinc phosphide poisoning. Clin Toxicol 2009;47:89-100. doi: 10.1080/1556365080252067510.1080/15563650802520675
- 2. Soltaninejad K, Nelson LS, Bahreini SA, Shadnia S. Fatal aluminum phosphide poisoning in Tehran-Iran from 2007 to 2010. Indian J Med Sci 2012;66:66-70. PMID: 23603623
- 3. Shadnia S, Sasanian G, Allami P, Hosseini A, Ranjbar A, Amini-Shirazi N, Abdollahi M. A retrospective 7-years study of aluminum phosphide poisoning in Tehran: opportunities for prevention. Hum Exp Toxicol 2009;28:209-13. doi: 10.1177/096032710809719410.1177/096032710809719419734272
- 4. Soltaninejad K, Faryadi M, Sardari F. Acute pesticide poisoning related deaths in Tehran during the period 2003-2004. J Forensic Leg Med 2007;14:352-4. doi: 10.1016/j.jflm.2006.12.01110.1016/j.jflm.2006.12.011
- 5. Shadnia S, Mehrpour O, Soltaninejad K. A simplified acute physiology score in the prediction of acute aluminum phosphide poisoning outcome. Indian J Med Sci 2010;64:532-39. PMID: 21258160
- 6. Mathai A, Bhanu MS. Acute aluminium phosphide poisoning: Can we predict mortality? Indian J Anaesth 2010;54:302-7. doi: 10.4103/0019-5049.6837210.4103/0019-5049.68372
- 7. Soltaninejad K, Beyranvand MR, Momenzadeh SA, Shadnia S. Electrocardiographic findings and cardiac manifestations in acute aluminum phosphide poisoning. J Forensic Leg Med 2012;19:291-93. doi: 10.1016/j.jflm.2012.02.00510.1016/j.jflm.2012.02.005
- 8. Alter P, Grimm W, Maisch B. Lethal heart failure caused by aluminium phosphide poisoning. Intensive Care Med 2001;27:327. PMID: 11280664
- 9. Taghaddosinejad F, Farzaneh E, Ghazanfari-Nasrabad M, Eizadi-Mood N, Hajihosseini M, Mehrpour O. The effect of N-acetyl cysteine (NAC) on aluminum phosphide poisoning inducing cardiovascular toxicity: a case-control study. Springerplus 2016;5:1948. doi: 10.1186/s40064-016-3630-210.1186/s40064-016-3630-2
- 10. Moghadamnia AA. An update on toxicology of aluminum phosphide. DARU 2012;20:25. doi: 10.1186/2008-2231-20-25
- 11. Naccarelli GV, Wolbrette DL, Patel HM, Luck JC. Amiodarone: clinical trials. Curr Opin Cardiol 2000;15:64-72. PMID: 10666663
- 12. Brendorp B, Pedersen O, Torp-Pedersen C, Sahebzadah N, Køber L. A benefit-risk assessment of class III antiarrhythmic agents. Drug Saf 2002;25:847-65. doi: 10.2165/00002018-200225120-0000310.2165/00002018-200225120-00003
- 13. Susla GM, Suffredini AF, McAreavey D, Solomon MA, Hoffman WD, Nyquist P, Ognibene FP, Shelhamer JH, Masur H, editors. Handbook of Critical Care Drug Therapy. Philadelphia: Lippincott Williams & Wilkins; 2006.
- 14. Jadhav AP, Nusair MB, Ingole A, Alpert MA. Unresponsive ventricular tachycardia associated with aluminum phosphide poisoning. Am J Emerg Med 2012;30:633.e3-5. doi: 10.1016/j.ajem.2011.01.02610.1016/j.ajem.2011.01.026
- 15. Siwach SB, Singh H, Jagdish, Katyal VK, Bhardwaj G. Cardiac arrhythmias in aluminium phosphide poisoning studied by on continuous holter and cardioscopic monitoring. J Assoc Physicians India 1998;46:598-601. PMID: 12152839
- 16. Jafari A, Baghaei A, Solgi R, Baeeri M, Chamanara M, Hassani S, Gholami M, Ostad SN, Sharifzadeh M, Abdollahi M. An electrocardiographic, molecular and biochemical approach to explore the cardioprotective effect of vasopressin and milrinone against phosphide toxicity in rats. Food Chem Toxicol 2015;80:182-92. doi: 10.1016/j.fct.2015.02.02210.1016/j.fct.2015.02.022
- 17. Baghaei A, Solgi R, Jafari A, Abdolghaffari AH, Golaghaei A, Asghari MH, Baeeri M, Ostad SN, Sharifzadeh M, Abdollahi M. Molecular and biochemical evidence on the protection of cardiomyocytes from phosphine-induced oxidative stress, mitochondrial dysfunction and apoptosis by acetyl-L-carnitine. Environ Toxicol Pharmacol 2016;42:30-7. doi: 10.1016/j.etap.2015.12.01910.1016/j.etap.2015.12.019
- 18. Azad A, Lall SB, Mittra S. Effect of N-acetylcysteine and L-NAME on aluminium phosphide induced cardiovascular toxicity in rats. Acta Pharmacol Sin 2001;22:298-304. PMID: 1174258111742581